In new Nature paper, Raze Therapeutics co-founder David Sabatini discovers role for 1C metabolism in glioblastoma 2015/04/08 SHMT2 drives glioma cell survival in ischaemia but imposes a dependence on glycine clearance. Press Release
In new Nature paper, Raze Therapeutics co-founder David Sabatini discovers role for 1C metabolism in glioblastoma 2015/04/08
